iShares U.S. Pharmaceutical ETFiShares U.S. Pharmaceutical ETFiShares U.S. Pharmaceutical ETF

iShares U.S. Pharmaceutical ETF

No trades
See on Supercharts

Key stats

Assets under management (AUM)
‪646.91 M‬USD
Fund flows (1Y)
‪207.82 M‬USD
Dividend yield (indicated)
1.42%
Discount/Premium to NAV
1.5%

About iShares U.S. Pharmaceutical ETF

Issuer
BlackRock, Inc.
Brand
iShares
Expense ratio
0.40%
Home page
Inception date
May 1, 2006
Index tracked
DJ US Select / Pharmaceutical
Management style
Passive
IHE tracks a broad index of US pharmaceutical companies. The fund provides exposure to the manufacturers of prescription or over-the-counter drugs, such as aspirin, cold remedies and birth control pills. The index also includes vaccine producers. IHE may also include companies of all sizes, ranging from large- to small-cap. The index weights its constituents by market cap, with a cap of up to 22.5% per individual company and is rebalanced quarterly. IHE uses a sampling strategy that involves investing in a representative sample of securities that collectively has an investment profile similar to that of an applicable underlying index. Index components are selected on an annual basis.

Classification

Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Pharmaceuticals
Strategy
Vanilla
Weighting scheme
Market cap
Selection criteria
Market cap

Returns

1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund

As of April 30, 2024
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks99.90%
Health Technology99.90%
Bonds, Cash & Other0.10%
Mutual fund0.10%
Cash0.00%
Stock breakdown by region
100%
North America100.00%
Latin America0.00%
Europe0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends

Dividend payout history

Assets under management (AUM)

Fund Flows